Sabyasachi Sen, M.D., FRCP, FACP, FACE, associate professor of medicine at the George Washington University (GW) School of Medicine and Health Sciences and a practicing physician in the Division of Endocrinology at the GW Medical Faculty Associates, has been indoctrinated as a fellow of the Royal College of Physicians in Edinburgh, Scotland.
This fellowship is awarded to physicians who have demonstrated continued commitment to medical education and research, worldwide. It recognizes consultants or attendings for their clinical achievement, confers international peer recognition, and presents enhanced professional opportunities to contribute to standard-setting activities.
Sen’s basic research interest involves behavior (survival and differentiation) of human adult stem cells in hyperglycemia. His current research projects include: the effect of exercise and incretins on endothelial dysfunction and endothelial progenitor cells in patients with Prediabetes and early type 2 diabetes; use of apoptosis resistant endothelial progenitor cells to increase collateral vessel formation in diabetes with peripheral vascular disease; and use of genetically engineered mesenchymal stem cells to reduce inflammation and insulin resistance in diabetes. In 2012, he received the American Heart Association’s Scientific Development Grant and Investigator Initiated Study Grant from the Together on Diabetes Project, a scientific grant funding mechanism from Astra Zeneca. In 2015 and 2016 he received two more three-year Investigator Initiated Study (IIS) grants to investigate the effect of two new diabetes medications, Linagliptin and Canagliflozin, on blood vessels and endothelial progenitor cells in patients with Type 2 diabetes. His clinical interest includes prevention and treatment of diabetes and primary lipid disorders.
Sen attended medical school at Calcutta University in India. He completed his internal medicine residency from Tufts University School of Medicine and a fellowship in endocrinology from the National Institute of Diabetes and Digestive and Kidney Diseases. He undertook extensive training both as a clinician and as a translational science researcher in internal medicine and endocrinology from Britain and Ireland before training in the U.S. Previously, he was an endocrinology faculty member at Tufts University School of Medicine. He is also a fellow of the American College of Physicians and American College of Endocrinology.
Each year around 400 physicians from across the world are elected to the Fellowship of the Royal College of Physicians of Edinburgh in recognition of their achievements. To learn more, visit the RCPE site.
